[1]谭欢,张远理,唐原,等.瘢痕疙瘩患者128例生活质量评估及影响因素分析[J].中国皮肤性病学杂志,2021,(02):200-204.
　TAN Huan,ZHANG Yuanli,TANG Yuan,et al.Assessment of Quality of Life and Analysis of Influencing Factors in Patients with Keloids[J].The Chinese Journal of Dermatovenereology,2021,(02):200-204.
点击复制

瘢痕疙瘩患者128例生活质量评估及影响因素分析()
分享到：

《中国皮肤性病学杂志》[ISSN:1001-7089/CN:61-1197/R]

卷:
期数:
2021年02期
页码:
200-204
栏目:
调查报告
出版日期:
2021-02-01

文章信息/Info

Title:
Assessment of Quality of Life and Analysis of Influencing Factors in Patients with Keloids
文章编号:
1001-7089(2021)02-0200-05
作者:
谭欢; 张远理; 唐原; 杨芳; 谢续娥; 祝守敏; 向光; 黎斌
重庆三峡医药高等专科学校附属医院皮肤科,重庆 万州 404000
Author(s):
TAN Huan; ZHANG Yuanli; TANG Yuan; YANG Fang; XIE Xu'e; ZHU Shoumin; XIANG Guang; LI Bin
(Department of Dermatology,the Affiliated Hospital of Chongqing Three Gorges Medical College,Chongqing 404000,China)
关键词:
瘢痕疙瘩;  皮肤病生活质量指数;  生活质量;  影响因素
Keywords:
Keloids;  Dermatology life quality index;  Quality of life;  Influencing factors
分类号:
R 739.5
文献标志码:
B
摘要:
目的 评估瘢痕疙瘩对患者生活质量的影响,并分析其影响因素。方法 应用皮肤病生活质量指数(dermatology life quality index,DLQI)评估瘢痕疙瘩患者的生活质量。结果 共调查了128例瘢痕疙瘩患者,DLQI得分为0～23分,平均为(7.12±4.68)分,患者瘢痕评估量表(patient scar assessment scale,PSAS)评分总分为14～58分,平均分为(32.67±8.81)分,患者瘢痕自我观感综合评分为3～10分,平均分为6.98±1.58。患者DLQI评分中,单身者(9.42±5.00)、高学历者(8.89±5.09)、年龄<40岁(8.12±4.92)、发病年龄<20岁(8.70±4.40)、病程<1年(9.72±4.77)及皮损位于暴露部位(9.52±4.67)分别高于非单身者(5.27±3.46)、低学历者(5.82±3.91)、年龄≥40岁(5.07±3.38)、发病年龄≥20岁(6.63±4.68)、病程≥1年(6.25±4.34)及皮损位于非暴露部位患者(6.59±4.54),差异有统计学意义。瘢痕疙瘩的厚度、硬度、颜色、不规则、综合评分及总分与患者的生活质量指数评分呈正相关(r为0.231～0.391,P<0.05),而瘢痕疙瘩的疼痛和瘙痒评分与患者的生活质量指数评分无相关性。结论 瘢痕疙瘩对患者的生活质量有中等程度的影响,其影响因素包括患者的婚姻状况、文化程度、年龄、发病年龄、病程、皮损部位。瘢痕疙瘩在美容形象学上的改变对患者生活质量的影响比其自觉症状所带来的影响更大。
Abstract:
Objective To assess quality of life and analyse influencing factors in patients with keloids.Methods The dermatology life quality index DLQI(DLQI)was used to evaluate the quality of life in patients with keloids.Results A total of 128 cases of keloids were investigated,the DLQI value varied from 0 to 23 with an average of 7.12±4.68,the total score of PSAS varied 14 to 58 with an average of 32.67±8.81,the score of overall opinion ranged 3 to 10 with an average 6.98±1.58.Patients with keloids who were single(9.42±5.00),high educational level(8.89±5.09),age<40 years(8.12±4.92),age of onset <20 years(8.700±4.40),the duration of the disease<12 months(9.72±4.77),and visible lesion(9.52±4.67)showed higher DLQI scores than those who were non-single(5.27±3.46),low educational level(5.82±3.91),age≥40 years(5.07±3.38),age of onset ≥20 years(6.63±4.68),the duration of the disease≥12 months(6.25±4.34),and invisible lesion(6.59±4.54)(all P<0.05).Scar thickness,stiffness,colour,irregularity and overall opinion were correlated to quality of life in patients with keloids(r ranged 0.231 to 0.391,P<0.05),while pain and itch were not correlated.Conclusion Keloids has a moderate impact on the quality of life in the patients.The affected factors include Marital status,educational level,age,age of onset,disease duration and location of skin lesions.Cosmetic factors were more associated with the quality of life impairment than pain and itch in patients with keloids.

参考文献/References:

[1] 朱莲花,李美玲,李周娜,等.瘢痕疙瘩发病机制的研究[J].中国皮肤性病学杂志,2017,31(5):560-562.
[2] Lee SS,Yosipovitch G,Chan YH,et al.Pruritus,pain,and small nerve fiber function in keloids:a controlled study [J].J Am Acad Dermatol,2004,51(6):1002-1006.
[3] Reinholz M,Poetschke J,Schwaiger H, et al.The dermato-logy life quality index as a means to assess life quality in patients with different scar types [J].J Eur Acad Dermatol Venereol,2015,29(11):2112-2119.
[4] Balci DD,Inandi T,Dogramaci CA,et al.DLQI scores in patients with keloids and hypertrophic scars:a prospective case control study [J].J Dtsch Dermatol Ges,2009,7(8):688-692.
[5] Ghazawi FM,Zargham R,Gilardino MS,et al.Insights into the pathophysiology of hypertrophic scars and keloids:how do they differ? [J]. Adv Skin Wound Care,2018,31(1):582-595.
[6] Bock O,Schmid-Ott G,Malewski P,et al.Quality of life of patients with keloid and hypertrophic scarring [J].Arch Dermatol Res,2006,297(10):433-438.
[7] Bijlard E,Kouwenberg CA,Timman R,et al.Burden of keloid disease:a cross-sectional health-related quality of life assessment [J].Acta Derm Venereol,2017,97(2):225-229.
[8] Draaijers LJ,Tempelman FR,Botman YA,et al.The patient and observer scar assessment scale:a reliable and feasible tool for scar evaluation [J].Plastic Reconstr Surg,2004,113(7):1960-1965.
[9] 施晓晓,汤諹.瘢痕评估量表的文献复习[J].中国皮肤性病学杂志,2014,28(5):527-529.
[10] 王晓玲,赵天恩,张喜芹.简体中文版皮肤病生活质量指标信度和效度初探[J].中华流行病学杂志,2004,25(9):791-793.
[11] Poetschke J,Reinholz M,Schwaiger H,et al.DLQI and POSAS scores in keloid patients [J].Facial Plast Surg,2016,32(3):289-295.
[12] 谭欢,兰雪梅,周村建,等.斑秃患者生活质量评估及皮肤病生活质量指数的信度分析及因子分析[J].临床皮肤科杂志,2015,44(6):356-360.
[13] 张敏,汪盛,张谊之,等.银屑病患者生活质量调查[J].临床皮肤科杂志,2006,35(6):370-372.
[14] 兰雪梅,谭欢,杨希川.男性雄激素性秃发患者生活质量调查[J].临床皮肤科杂志,2015,44(7):417-419.
[15] Arno AI,Gauglitz GG,Barret JP,et al.Up-to-date approach to manage keloids and hypertrophic scars:a useful guide[J].Burns,2014,40(7):1255-1266.
[16] Ojeh N,Bharatha A,Gaur U,et al.Keloids:Current and emerging therapies[J].Scars Burn Heal,2020,6:2059513120940499.

相似文献/References:

[1]刘晶,马红兵,王娟,等.术前注射和术中瘢痕核心切除术联合术后放疗治疗耳部瘢痕疙瘩20例临床观察[J].中国皮肤性病学杂志,2016,(09):961.[doi:10.13735/j.cjdv.1001-7089.201603010]
　LIU Jing,MA Hong-bing,WANG Juan,et al.Clinical Observation of Combined Preoperative Injection, Core Excision and Postsurgical Radiotherapy for Earlobe Keloid[J].The Chinese Journal of Dermatovenereology,2016,(02):961.[doi:10.13735/j.cjdv.1001-7089.201603010]
[2]宋勋,唐苏为,姜文成,等.中药药浴联合NB-UVB照射治疗稳定期寻常性银屑病及其对患者生活质量的影响[J].中国皮肤性病学杂志,2017,(07):757.[doi:10.13735/j.cjdv.1001-7089.201612075]
　SONG Xun,TANG Su-wei,JIANG Wen-cheng,et al.The Improvement of Life Quality of Patients with Psoriasis Vulgaris Following Combined Treatment of Chinese Herbal Bath and NB-UVB[J].The Chinese Journal of Dermatovenereology,2017,(02):757.[doi:10.13735/j.cjdv.1001-7089.201612075]
[3]南美兰,金哲虎,金承龙.4-HPR对瘢痕疙瘩成纤维细胞Procollagen Ⅰ、MMP-1及信号通路PI3K/Akt的影响[J].中国皮肤性病学杂志,2018,(03):245.[doi:10.13735/j.cjdv.1001-7089.201710044]
　NAN Meilan,JIN Zhehu,JIN Chenglong.The Effect of 4-hydroxyphenyl-Retinamide on Expression of Type Ⅰ Pro-collagen, MMP-1 and Signaling Pathway PI3K/Akt in Keloid Fibroblasts[J].The Chinese Journal of Dermatovenereology,2018,(02):245.[doi:10.13735/j.cjdv.1001-7089.201710044]
[4]肖婧,张良,陈柳青.隆突性皮肤纤维肉瘤误诊为瘢痕疙瘩1例分析[J].中国皮肤性病学杂志,2014,(06):642.[doi:10.13735/j.cjdv.1001-7089.2014.0642]
　XIAO Jing,ZHANG Liang,CHEN Liu-qing.A Case Analysis of Dermatofibrosarcoma Protuberans Misdiagnosed as Keloid[J].The Chinese Journal of Dermatovenereology,2014,(02):642.[doi:10.13735/j.cjdv.1001-7089.2014.0642]
[5]张大维,路永红,裴宝强,等.阿维A对瘢痕疙瘩成纤维细胞生长和凋亡的影响[J].中国皮肤性病学杂志,2018,(12):1373.[doi:10.13735/j.cjdv.1001-7089.201803117]
　ZHANG Dawei,LU Yonghong,PEI Baoqiang,et al.Influence of Acitretin on the Growth and Apoptosis of Keloid Fibroblasts[J].The Chinese Journal of Dermatovenereology,2018,(02):1373.[doi:10.13735/j.cjdv.1001-7089.201803117]
[6]王镜涵,白欣冉,董彦慧,等.A型肉毒素与曲安奈德治疗瘢痕疙瘩的长期疗效对比[J].中国皮肤性病学杂志,2019,(10):1149.[doi:10.13735/j.cjdv.1001-7089.201811161]
　WANG Jinghan,BAI Xinran,DONG Yanhui,et al.Comparison of Long-term Efficacy of Botulinum Toxin Type A and Triamcinolone Acetonide for Keloid[J].The Chinese Journal of Dermatovenereology,2019,(02):1149.[doi:10.13735/j.cjdv.1001-7089.201811161]
[7]李初颖,金珊,金哲虎,等.内、外源性凋亡通路在瘢痕疙瘩中的研究进展[J].中国皮肤性病学杂志,2020,(05):588.[doi:10.13735/j.cjdv.1001-7089.201906140]
　LI Chuying,JIN Shan,JIN Zhehu,et al.Advances in Research of Endogenous and Exogenous Apoptosis Pathways in Keloids[J].The Chinese Journal of Dermatovenereology,2020,(02):588.[doi:10.13735/j.cjdv.1001-7089.201906140]
[8]崔晶,金哲虎,金珊,等.多配体蛋白聚糖-1对瘢痕疙瘩成纤维细胞增殖及迁移的影响[J].中国皮肤性病学杂志,2020,(06):617.[doi:10.13735/j.cjdv.1001-7089.201908144]
　CUI Jing,JIN Zhehu,JIN Shan,et al.Effects of Syndecan-1 on Proliferation and Migration of Keloid Fibroblasts[J].The Chinese Journal of Dermatovenereology,2020,(02):617.[doi:10.13735/j.cjdv.1001-7089.201908144]
[9]崔晶,金承龙,金珊,等.EMT在瘢痕疙瘩中的作用研究进展[J].中国皮肤性病学杂志,2021,(02):217.
　CUI Jing,JIN Chenglong,JIN Shan,et al.Recent Advance in the Role of EMT in Keloid[J].The Chinese Journal of Dermatovenereology,2021,(02):217.

更新日期/Last Update: 2021-02-01